Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Detmar

Showing results (21-30 of 219) with videos related to

Pageof 22
Sort By:
Advanced Drug Delivery Reviews|December 27, 2015
Tumor lymphangiogenesis and new drug developmentLothar C Dieterich, Michael Detmar
Current Issues in Molecular Biology|June 9, 2022
Sostdc1 Secreted from Cutaneous Lymphatic Vessels Acts as a Paracrine Factor for Hair Follicle GrowthSun-Young Yoon, Michael Detmar
Hematology/Oncology Clinics of North America|October 12, 2004
Angiogenesis and lymphangiogenesis of skin cancersSoheil S Dadras, Michael Detmar
Journal of Leukocyte Biology|June 24, 2006
Tumor and lymph node lymphangiogenesis--impact on cancer metastasisNadja E Tobler, Michael Detmar
Experimental Cell Research|March 10, 2009
Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functionsLeah N Cueni, Michael Detmar
Cell and Tissue Research|July 29, 2003
Prox1, master regulator of the lymphatic vasculature phenotypeYoung-Kwon Hong, Michael Detmar
The American Journal of Pathology|September 28, 2006
Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel functionKentaro Kajiya, Satoshi Hirakawa, Michael Detmar
The American Journal of Pathology|December 28, 2011
Inflammation-induced lymph node lymphangiogenesis is reversibleViviane Mumprecht, Filip Roudnicky, Michael Detmar
The Journal of Investigative Dermatology|May 2, 2002
Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damageKiichiro Yano, Hajimu Oura, Michael Detmar
Advanced Drug Delivery Reviews|February 15, 2014
Lymphatics in nanophysiologySatoshi Hirakawa, Michael Detmar, Sinem Karaman
Pageof 22

Showing results (21-30 of 219) with videos related to

Sort By:
Pageof 22
Advanced Drug Delivery Reviews|December 27, 2015
Tumor lymphangiogenesis and new drug developmentLothar C Dieterich, Michael Detmar
Current Issues in Molecular Biology|June 9, 2022
Sostdc1 Secreted from Cutaneous Lymphatic Vessels Acts as a Paracrine Factor for Hair Follicle GrowthSun-Young Yoon, Michael Detmar
Hematology/Oncology Clinics of North America|October 12, 2004
Angiogenesis and lymphangiogenesis of skin cancersSoheil S Dadras, Michael Detmar
Journal of Leukocyte Biology|June 24, 2006
Tumor and lymph node lymphangiogenesis--impact on cancer metastasisNadja E Tobler, Michael Detmar
Experimental Cell Research|March 10, 2009
Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functionsLeah N Cueni, Michael Detmar
Cell and Tissue Research|July 29, 2003
Prox1, master regulator of the lymphatic vasculature phenotypeYoung-Kwon Hong, Michael Detmar
The American Journal of Pathology|September 28, 2006
Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel functionKentaro Kajiya, Satoshi Hirakawa, Michael Detmar
The American Journal of Pathology|December 28, 2011
Inflammation-induced lymph node lymphangiogenesis is reversibleViviane Mumprecht, Filip Roudnicky, Michael Detmar
The Journal of Investigative Dermatology|May 2, 2002
Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damageKiichiro Yano, Hajimu Oura, Michael Detmar
Advanced Drug Delivery Reviews|February 15, 2014
Lymphatics in nanophysiologySatoshi Hirakawa, Michael Detmar, Sinem Karaman
Pageof 22